Your browser doesn't support javascript.
loading
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.
de Kouchkovsky, Ivan; Rao, Arpit; Carneiro, Benedito A; Zhang, Li; Lewis, Catriona; Phone, Audrey; Small, Eric J; Friedlander, Terence; Fong, Lawrence; Paris, Pamela L; Ryan, Charles J; Szmulewitz, Russell Z; Aggarwal, Rahul.
Afiliação
  • de Kouchkovsky I; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Rao A; Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
  • Carneiro BA; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Zhang L; Department of Medicine, Lifespan Cancer Institute, Brown University, Providence, Rhode Island.
  • Lewis C; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Phone A; School of Medicine, University of California, Irvine, Irvine, California.
  • Small EJ; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Friedlander T; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Fong L; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Paris PL; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Ryan CJ; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Szmulewitz RZ; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Aggarwal R; Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Clin Cancer Res ; 28(8): 1531-1539, 2022 04 14.
Article em En | MEDLINE | ID: mdl-35176163
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article